Pacific Biosciences Financial Overview
Pacific Biosciences's market cap is currently $549.47M. The company's EPS TTM is $-0.13; its P/E ratio is -0.84; Pacific Biosciences is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
